FCGR3A and acute myeloid leukemia: Next, we investigated whether the in vitro activity of AFM28 translates into anti-leukemic activity in vivo using a disseminated AML cell line model in mice transgenic for human CD16A expressed on endogenous murine innate immune effector cells.